Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Restorbio Inc (TORC)

2.28   -0.03 (-1.3%) 08-13 16:00
Open: 2.31 Pre. Close: 2.31
High: 2.38 Low: 2.26
Volume: 279,217 Market Cap: 83M
resTORbio, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of aging-related diseases primarily in the United States. Its lead program inhibits the target of rapamycin complex 1 or TORC1, a pathway that contributes to the age-related decline in function of multiple organ systems. The company's lead product candidate is RTB101, an orally administered, small molecule, potent TORC1 inhibitor that binds to the active site of mTOR on the TORC1 complex. It has initiated a Phase 1b/2a clinical trial of RTB101 alone or in combination with sirolimus in progressive neurodegenerative disease. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.383 - 2.402 2.402 - 2.415
Low: 2.221 - 2.242 2.242 - 2.256
Close: 2.253 - 2.285 2.285 - 2.307

Technical analysis

as of: 2020-08-13 4:39:01 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.21     One year: 3.62
Support: Support1: 2.19    Support2: 1.82
Resistance: Resistance1: 2.75    Resistance2: 3.10
Pivot: 2.49
Moving Average: MA(5): 2.40     MA(20): 2.54
MA(100): 1.93     MA(250): 3.41
MACD: MACD(12,26): 0.01     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 15.62     %D(3): 26.27
RSI: RSI(14): 44.62
52-week: High: 11.00  Low: 0.86  Change(%): -77.2
Average Vol(K): 3-Month: 118421  10-Days: 56201

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
TORC has closed above bottom band by 3.9%. Bollinger Bands are 10.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 04 Aug 2020
TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence Platform to Investigate RTB-101 for COVID-19 - BP Journal

Fri, 31 Jul 2020
resTORbio Inc. (TORC) Moves 9.68% Higher: These Numbers are Too Good to be True - News Daemon

Thu, 30 Jul 2020
resTORbio Provides Corporate Update and Reports Second Quarter 2020 Financial Results - GlobeNewswire

Tue, 28 Jul 2020
resTORbio and TrialSpark collaborate to investigate RTB-101 for COVID-19 on the Project Covalence platform - PRNewswire

Tue, 28 Jul 2020
Is resTORbio, Inc. (TORC) Stock a Great Value? - InvestorsObserver

Tue, 28 Jul 2020
resTORbio Announces an Award from the National Institute on Aging to Fund a Pilot Study of RTB101 as COVID-19 Prophylaxis in Older Adults - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 36
Shares Float (M) 26
% Held by Insiders 15.95
% Held by Institutions 39.51
Shares Short (K) 561
Shares Short P. Month (K) 693

Stock Financials

EPS -2.176
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.080
Profit Margin
Operating Margin
Return on Assets (ttm) -45.0
Return on Equity (ttm) -72.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.204
Qtrly Earnings Growth
Operating Cash Flow (M) -77
Levered Free Cash Flow (M) -48

Stock Valuations

PE Ratio -1.05
PEG Ratio
Price to Book value 1.10
Price to Sales
Price to Cash Flow -1.08

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.